Trial results of vemurafenib, cobimetinib and LDH as a predictive marker in BRAF-mutated melanoma
Looking towards the future: what is in store for the treatment of bladder cancer?
The use of mouse models in melanoma with brain metastases to test new therapies
Availability of clinical trials for patients with brain metastases and more aggressive diseases
Melanoma Patient Network Europe sessions at ESMO 2016